The earlier the diagnosis is made, the higher the chances of recovery. However 55% of annual cancer cases do not have traditional early detection methods. This is where it comes to the rescue Krebs-Scan: The program can be used to detect a wide range of potentially dangerous tumors, i.e. both cancer and precancerous conditions - even in early, asymptomatic stages. This also includes cancers for which there are currently no traditional cancer screening methods. It does Krebs-Scan An ideal complement to traditional early detection methods.
Unfortunately, cancer is the second leading cause of death in Germany. Many cancer-related deaths are preventable. The fight is being fought through many measures, large and small, in the areas of prevention, diagnosis, therapy and early detection of potentially dangerous tumors.
The insurance company HanseMerkur offers innovative program for early detection of cancer – KREBS-SCAN.
This new program helps to detect precancerous and malignant neoplasms at a very early, asymptomatic stage, including those types of tumors for which there was no legally confirmed early detection.
This can be done very simply - only one blood test per year.
Combination of innovative blood test PanTum Detect® and today's best imaging techniques, such as MRI and PET/CT, are optimal addition to existing early detection programs offered by public and private health insurance. Related services and specialists help ensure the best treatment and recovery in case of illness.
Basic moments Krebs-Scan Action
- Annual screening blood test for cancer
- If suspected, further diagnosis using computed and / or magnetic resonance imaging
- Constant competent support of oncologists by phone or online
How does it work?
Cancer scanning is based on PanTum innovative blood test Detect®. In case of suspicion, specialists clarify the result with the help of imaging procedures. Visualization used with PET/CT and MRI, is currently the best method for diagnosing tumor localization and is considered gold standard.
If the image confirms the initial suspicion, the specialist will proceed with further actions. This includes, for example, additional examinations to more accurately tumor definitions and, if necessary, treatment and therapy .
After completion of oncological surveillance, annual blood tests should be started again.
Advantages Krebs-Scan
Services
Krebs-Scan
Tariff ZY
Annual early screening with PanTum Detect®.
Follow-up examinations to clarify and localize the cancer using imaging techniques (PET/CT and MRI).
Related services in the treatment of diagnosed cancer.
In the event of a hospital stay:
Accommodation in a single or double room with treatment by the head physician or replacement daily sick leave in the amount of 75 euros per day.
Fare.
Daily spa compensation of EUR 75 for up to 42 days.
Medical help by phone or online.
There is no waiting time.
Research methodology
PanTum Detect® detects special enzymes in phagocytes (macrophages) in the blood, which in many tumors are produced in large quantities already in the early asymptomatic stages.
- Enzyme TKTL1 plays a role in glucose metabolism and is present in higher concentrations in many cancer cells.
- Enzyme DNAseX (Apo10) participates in the programmed death of damaged cells and in most cases is found in higher concentrations in cancer cells whose cell death is impaired.
Results of clinical trials of the program
- The PanTum Detect® blood test in 8 out of 10 cases in asymptomatic individuals provided sufficient suspicion for the presence of potentially malignant tumors (cancerous and precancerous) to justify the use of imaging techniques to check and localize.
- In the study, the evidence came at a time when most cases had a good chance of recovery.
- When used annually, PanTum Detect® can improve the chances of detecting potentially dangerous tumors at an early stage and, therefore, improve treatment options.
Take part in the program
early detection of cancer from the insurance company HanseMerkur you can already now.
First year
19,83 € per month
more... 27,50 € per month
from 70 years old – up to 45,30 € per month
Where can I get tested
Click on the map to find and select a location where PanTum Detect® examinations are conducted under the Program and assign a term.
Still have questions?
“During the clinical trials, 5114 asymptomatic patients aged 50 to 70 years were examined and 124 patients tested positive – a rate of 2,4%.”
Regarding the above, the following questions arise:
Where, by whom and when were the studies, the results of which are given above, carried out?
Can the authors of the article answer the standard questions for evaluating the study on the study of the proposed diagnostic test:
1. Is there a comparison with the “gold standard”?
2. Is this comparison blind?
3. Is the method of formation of the studied group of patients clearly described?
4. Did the examined patients have a sufficiently wide range of diseases (mild and severe cases, treated and untreated, with lesions of various forms, with concomitant diseases?
5. Has the reproducibility of the test results been assessed?
6. Has blind interpretation been assessed for reliability?
7. Is the “norm” — the absence of disease — rationally defined?
8. If a test is offered as an adjunct to a suite of other tests, has this test been shown to improve overall diagnostic outcome?
9. Is the “separation point” between healthy and sick justified?
10. Is the tactics of applying the test described in sufficient detail so that you can use it correctly?
11. Has the overall usefulness of the test been assessed?
Hello.
Your questions are clearly of a professional nature and in order not to be spoiled by the phone, I would recommend that you ask them to Zyagnum AG, who conduct this testing.
Also, there are already enough official scientific articles in the public domain regarding this method.
This annual study does not cancel regular checks for compulsory medical insurance, but is an additional way to detect cancer, and also allows (if a disease is detected) to spend a period of treatment and rehabilitation with greater comfort